Multiple sclerosis and Multiple sclerosis relapse - from FDA reports

Summary

Multiple sclerosis relapse is found among people with Multiple sclerosis, especially for people who are female, 40-49 old, take medication Tysabri and have Depression. This review analyzes which people have Multiple sclerosis relapse with Multiple sclerosis. It is created by eHealthMe based on reports of 37,248 people who have Multiple sclerosis from FDA , and is updated regularly.

What to expect?

If you have Multiple sclerosis and Multiple sclerosis relapse, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who have Multiple sclerosis and Multiple sclerosis relapse

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 22, 2017

37,248 people who have Multiple Sclerosis and Multiple Sclerosis Relapse are studied.


Number of reports submitted per year:

Would you have Multiple sclerosis relapse when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experience Multiple Sclerosis Relapse *:

  • female: 78.65 %
  • male: 21.35 %

Age of people who have Multiple Sclerosis and experience Multiple Sclerosis Relapse *:

  • 0-1: 0.01 %
  • 2-9: 0.06 %
  • 10-19: 0.99 %
  • 20-29: 9.12 %
  • 30-39: 20.51 %
  • 40-49: 30.16 %
  • 50-59: 26.63 %
  • 60+: 12.52 %

Top co-existing conditions for these people *:

  • Depression (720 people, 1.93%)
  • Pain (616 people, 1.65%)
  • High Blood Pressure (513 people, 1.38%)
  • Gait Disturbance (510 people, 1.37%)
  • Muscle Spasms (357 people, 0.96%)

Most common drugs for these people *:

  • Tysabri (15,282 people, 41.03%)
  • Avonex (10,691 people, 28.70%)
  • Rebif (3,332 people, 8.95%)
  • Tecfidera (2,829 people, 7.60%)
  • Copaxone (2,535 people, 6.81%)

Top symptoms for these people *:

  • Fatigue (4,193 people, 11.26%)
  • Weakness (3,866 people, 10.38%)
  • Fall (3,333 people, 8.95%)
  • Gait Disturbance (3,215 people, 8.63%)
  • Hypoaesthesia (2,852 people, 7.66%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Multiple sclerosis relapse and Multiple sclerosis?

Expand the study to include reports from both FDA and eHealthMe

Multiple sclerosis relapse and Multiple sclerosis from FDA and eHealthMe reports

Multiple Sclerosis

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Tysabri, Avonex, Rebif, Baclofen (latest reports from 463,870 Multiple sclerosis patients)

Multiple Sclerosis Relapse

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) has been reported by people with multiple sclerosis, relapsing-remitting multiple sclerosis, gait disturbance, depression, pain (latest reports from 45,135 Multiple sclerosis relapse patients).

Browse all symptoms of Multiple sclerosis

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Multiple sclerosis relapse

Multiple sclerosis relapse

Other conditions that could case Multiple sclerosis relapse

Multiple sclerosis relapse

Related studies

What would happen?

Forecast new side effects and undetected conditions when you have Multiple sclerosis and Multiple sclerosis relapse.

Can you answer these questions?

More questions >

You may be interested in these reviews

More reviews >